covid 19 News and Research

RSS

Mosquito excrement offers new way to detect circulating viruses

When public health researchers want to know whether diseases such as COVID-19 or polio are circulating in a community, they can look for genetic evidence in wastewater.

18 Sep 2026

SARS-CoV-2 protein ORF8 drives macrophage infection and lung inflammation

In the sickest COVID-19 patients, the SARS-CoV-2 virus doesn't just cause severe damage by directly infecting airway cells.

18 Sep 2026

Machine learning predicts psychosocial resilience among healthcare workers

A team of researchers trained three machine learning models-Logistic Regression, Random Forest, and Support Vector Machine (SVM)-to classify healthcare workers according to their level of psychosocial resilience, using information collected during the COVID-19 pandemic.

18 Sep 2026

New study defines rare TCF7L2-related neurodevelopmental disorder

Researchers have completed the largest study to date of TCF7L2-related neurodevelopmental disorder (TRND), a rare genetic condition caused by changes in the TCF7L2 gene, which plays an important role in brain development.

18 Sep 2026

US health officials knowingly relied on flawed vaccine safety algorithm

US health officials knowingly relied on a compromised algorithm to detect signals of harm from mRNA covid-19 vaccines and silenced efforts to fix it, finds an investigation published by The BMJ today.

17 Sep 2026

Innate immune system variations determine vaccine side effects

Redness and pain at the injection site, fever, fatigue or headaches: vaccines can cause side effects, but their frequency and severity vary considerably from person to person.

17 Sep 2026

SARS-CoV-2 uses two fusion keys to enter host cells

To enter our cells, the Covid-19 virus fuses its surrounding membrane with the membrane of the target cell.

17 Sep 2026

Genetic risk for PTSD varies across different types of trauma

A groundbreaking study reveals that your genes may make you more vulnerable to Post Traumatic Stress Disorder (PTSD) from certain types of trauma-particularly childhood neglect-than from others.

17 Sep 2026

Hedgehog coronaviruses reveal potential pathways for cross-species transmission

Washington State University researchers have discovered how a group of coronaviruses circulating in hedgehogs invades host cells, a key to understanding their potential to jump between species and their risk of causing a pandemic in humans.

16 Sep 2026

Imperial College London chemical engineer develops new technology to tackle global inequalities in vaccination coverage

A new technology that allows vaccines to be stored at room temperature in liquid form could tackle global health inequalities.

16 Sep 2026

Vulnerable adolescents face sharp drop in mental health service access

Some of the most vulnerable children and young people are failing to get access to mental health support despite much higher levels of need, according to new research from the University of Cambridge.

16 Sep 2026

Harvard scientists design evolutionary traps to stop viral mutations

When a virus mutates, the world usually finds out the hard way. Variants of influenza and SARS‑CoV‑2 can slip past vaccines and antibody drugs before scientists fully understand what has changed.

15 Sep 2026

Adolescent cannabis use disorder diagnoses rise after legalization

New diagnoses of cannabis use disorder (CUD) among adolescents in Northern California began climbing after recreational cannabis was legalized in California in 2016, reversing a steady decline in the three years prior, according to a new study published in the journal Addiction.

15 Sep 2026

Smartphone imaging accurately supports remote cataract referral decisions

Researchers have found a high level of agreement between cataract referral decisions based on smartphone images reviewed remotely and those made by ophthalmologists examining patients in person at rural eye camps.

15 Sep 2026

Targeted nanoparticles strengthen anti-cancer immune responses in tumors

Adelaide University researchers have developed a new way of using mRNA technology to reprogram tumor-supporting immune cells and strengthen the body's anti-cancer immune response.

11 Sep 2026

Updated COVID-19 vaccines protect adults with autoimmune rheumatic conditions

In an Arthritis & Rheumatology analysis of data on 60,980 US adults with autoimmune rheumatic conditions who developed COVID-19 between December 2020 and August 2024, those who received booster or updated (2023-2024) COVID-19 vaccines were less likely to be hospitalized for COVID-19 compared to those who received only the initial series vaccines or who were unvaccinated.

9 Sep 2026

New AI method tracks immune responses without known antibody databases

A research team comprising Associate Professor FUNAKOSHI Yohei, Associate Professor YAKUSHIJIN Kimikazu, Professor MINAMI Hironobu, and Associate Professor OHJI Goh of Kobe University, together with graduate student MASUDA Genki, then-graduate student IIZUMI Shunsuke, Associate Professor OHUE Masahito, and colleagues at the Institute of Science Tokyo, has developed a new analysis method, LM-QASAS.

9 Sep 2026

COVID-19 linked to lower subsequent risk of type 1 diabetes

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) shows that people who have had COVID-19 have a lower, rather than higher, risk of subsequent development of type 1 diabetes (T1D).

8 Sep 2026

Psilocybin microdosing sounds promising, but the strongest studies tell a different story

A systematic review of 11 studies involving 3,262 adults found that psilocybin mushroom and truffle microdosing was associated with reported improvements across areas including mental health, well-being, cognition, creativity, and social functioning. However, the evidence was methodologically weak and highly heterogeneous, the two placebo-controlled trials found no significant improvements, and inadequate adverse-event reporting means efficacy and safety remain uncertain.

7 Sep 2026

Independent review reinforces value of vaccines across all ages

The Gerontological Society of America (GSA) supports the 2026-27 respiratory season vaccine evidence review released on September 2, 2026, by the Vaccine Integrity Project (VIP) in collaboration with the American Medical Association.

4 Sep 2026